Issue |
BIO Web Conf.
Volume 33, 2021
The 1st International Conference of Advanced Veterinary Science and Technologies for Sustainable Development (ICAVESS 2021)
|
|
---|---|---|
Article Number | 06007 | |
Number of page(s) | 8 | |
Section | Veterinary Medicine and Science | |
DOI | https://doi.org/10.1051/bioconf/20213306007 | |
Published online | 23 August 2021 |
Oral subchronic toxicity of (+)-2,2’epicytoskyrin a on male mice (Mus musculus)
1
Museum Zoologicum Bogoriense, Research Center for Biology, Indonesian Institute of Sciences, Bogor, Indonesia
2
Department of Botany, Research Center for Biology, Indonesian Institute of Sciences, Bogor, Indonesia
3
Faculty of Veterinary Medicine, Gadjah Mada University, Yogyakarta, Indonesia.
* Corresponding author: kurniasih_1951@yahoo.co.id
(+)-2,2’Epicytoskyrin A (EpiA) is a secondary metabolite derived from an endophytic fungus Diaporthe sp. associated with the Gambier plant. EpiA has been reported to possess anticancer, antifungal, and antibacterial activities. In a mouse model, EpiA was also shown to low oral toxicity. Until now, there is no negative effect of EpiA reported yet. This study aimed to study the subchronic toxicity of this component in mice. This study used 60 male mice (Mus musculus) which were divided into four groups of treatments. Parameters that were analyzed were body weight, food consumption, blood chemicals, and histology. The results showed no significant difference in body weight gain and food consumption in all groups. Blood chemicals analysis showed increasing AST and ALT in dosage 12.5 mg/kg BW groups at day 90. Histological changes showed fatty degeneration and hydropic degeneration in the liver and mild inflammation in the kidney. No irreversible toxic effect of this component. So it can be beneficial for plant-based drug discovery. On the other hand, this study provides information about the safety of the development of EpiA as a drug candidate.
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.